Poniard Pharmaceuticals, Inc. (PARD)

[jhnvtjll]

Company terminated all of its employees on March 30, 2012, and has ceased substantially all of its operations.

From Form 8-K:
"The Company plans to seek short-term financing, which may be from a related party, to support minimal operations while the Company explores alternative sources of financing in order to continue its efforts to enter into an arrangement to support the continued development of its picoplatin product candidate."